TRIPLE-NEGATIVE BREAST CARCINOMA
Clinical trials for TRIPLE-NEGATIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new TRIPLE-NEGATIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for TRIPLE-NEGATIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can cutting calories help radiation fight breast cancer?
Disease control Recruiting nowThis study is testing if reducing calorie intake by 25% while receiving a highly focused, intense form of radiation before surgery helps shrink breast tumors more than radiation alone. It will involve 80 women with early-stage breast cancer. The goal is to see if this combined ap…
Matched conditions: TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Could some breast cancer patients avoid surgery?
Disease control Recruiting nowThis study is testing if breast cancer patients who respond exceptionally well to initial drug therapy can safely skip surgery or radiation. It is for women with early-stage breast cancer where a special biopsy shows no cancer remains after the drug treatment. The goal is to see …
Matched conditions: TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Faster radiation for breast cancer: can timing cut side effects?
Disease control Recruiting nowThis study is testing whether giving a shorter, more intense course of radiation therapy *before* breast cancer surgery is as safe and effective as giving it *after* surgery. It aims to see if the pre-surgery timing can reduce side effects and treatment time for 120 patients with…
Matched conditions: TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New hope for Tough-to-Treat breast cancer: trial tests Hormone-Blocking drug
Disease control Recruiting nowThis study is testing if adding a hormone-blocking drug called darolutamide to standard chemotherapy and immunotherapy before surgery works better for a specific type of early-stage, triple-negative breast cancer. About 51 patients with this cancer type will be randomly assigned …
Matched conditions: TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Vandana Abramson • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Custom-Made vaccine aims to train immune system to fight advanced cancers
Disease control Recruiting nowThis study is testing a new, personalized vaccine designed to target the unique proteins on a patient's own cancer cells. It is being given alongside an existing immunotherapy drug (pembrolizumab) to see if the combination is safe and can help control advanced solid tumors that h…
Matched conditions: TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Can a 'Brain Food' diet fight chemotherapy fog?
Symptom relief Recruiting nowThis study is testing whether following a specific healthy eating plan called the MIND diet can help reduce thinking and memory problems (often called 'chemobrain'), fatigue, and other symptoms in women undergoing chemotherapy for triple-negative breast cancer. Researchers will c…
Matched conditions: TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC
-
Can a 10-Week program ease the burden for breast cancer patients?
Symptom relief Recruiting nowThis study is testing whether a 10-week stress reduction and support program is practical and helpful for patients with triple-negative breast cancer. The program teaches relaxation, coping skills, and problem-solving, while also connecting participants with social workers to hel…
Matched conditions: TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated Mar 23, 2026 15:17 UTC
-
AI vs. human: can a chatbot bridge the genetic testing gap for cancer patients?
Knowledge-focused Recruiting nowThis study is testing whether a multilingual AI chatbot named PERLA can help more cancer patients get important genetic testing. It compares patients who learn about testing from the chatbot to those who learn from a human genetics counselor. The goal is to see if this technology…
Matched conditions: TRIPLE-NEGATIVE BREAST CARCINOMA
Phase: NA • Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC
-
Scientists build a living library of cancer to unlock treatment secrets
Knowledge-focused Recruiting nowThis study is collecting tissue and blood samples from cancer patients over time to create a research resource called a biobank. Researchers will analyze these samples to understand how cancer changes during treatment and why some treatments stop working. The goal is to help scie…
Matched conditions: TRIPLE-NEGATIVE BREAST CARCINOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 17, 2026 13:09 UTC